Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 18;13(8):2348.
doi: 10.3390/jcm13082348.

Risk Factors for Non-Adherence to Medication for Liver Transplant Patients: An Umbrella Review

Jordi Colmenero  1 , Mikel Gastaca  2 , Laura Martínez-Alarcón  3 , Cristina Soria  4 , Esther Lázaro  5 , Inmaculada Plasencia  6
Affiliations
Review

Risk Factors for Non-Adherence to Medication for Liver Transplant Patients: An Umbrella Review

Jordi Colmenero et al. J Clin Med. .

Abstract

Background/Objectives: Liver Transplantation (LT) is the second most common solid organ transplantation. Medication adherence on LT patients is key to avoiding graft failure, mortality, and important quality of life losses. The aim of this study is to identify risk-factors for non-adherence to treatment of liver transplant patients according to reliable published evidence. Methods: An umbrella review within the context of adherence to immunosuppressant medication of LT patients, was conducted. The review was performed in accordance with the principles of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines. Results: A total of 11 articles were finally included for the review. Non-adherence factors were identified and allocated using the WHO classification of factors for non-adherence. Each of these groups contains a subset of factors that have been shown to influence adherence to medication, directly or indirectly, according to literature findings. Conclusions: The results of the review indicate that sociodemographic factors, factors related to the patient, factors related to the treatment, condition-related and health system-related factors are good categories of predictors for both adherence and non-adherence to immunosuppressive medication in LT patients. This list of factors may help physicians in the treating and recognizing of patients with a potential risk of non-adherence and it could help in the designing of new tools to better understand non-adherence after LT and targeted interventions to promote adherence of LT patients.

Keywords: adherence; immunosuppressant medication; liver transplantation; non-adherence; umbrella review.

PubMed Disclaimer

Conflict of interest statement

L.M.-A., C.S. and E.L. have no conflicts to declare. J.C. has received speakers bureau from Chiesi, Astellas and Novartis. M.G. has received speakers bureau from Chiesi, Astellas and Novartis. I.P. has received speakers bureau from Chiesi and Astellas.

Figures

Figure 1
Figure 1
Prisma Flow chart.
See this image and copyright information in PMC

References

    1. Adam R., Karam V., Cailliez V., Grady J., Mirza D., Cherqui D., Klempnauer J., Salizzoni M., Pratschke J., Jamieson N., et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR)—50-year Evolution of Liver Transplantation. Transpl. Int. 2018;31:1293–1317. doi: 10.1111/tri.13358. - DOI - PubMed
    1. Kim S.-A., Kim E., Morris R.G., Park W.-S. Exploring the Non-Linear Relationship between Alcohol Consumption and Depression in an Elderly Population in Gangneung: The Gangneung Health Study. Yonsei Med. J. 2015;56:418–425. doi: 10.3349/ymj.2015.56.2.418. - DOI - PMC - PubMed
    1. Kwong A.J., Ebel N.H., Kim W.R., Lake J.R., Smith J.M., Schladt D.P., Schnellinger E.M., Handarova D., Weiss S., Cafarella M., et al. OPTN/SRTR 2021 Annual Data Report: Liver. Am. J. Transplant. 2023;23:S178–S263. doi: 10.1016/j.ajt.2023.02.006. - DOI - PubMed
    1. Global Observatory of Donation and Transplantation. [(accessed on 9 October 2023)]. Available online: https://www.transplant-observatory.org/
    1. Rinella M.E., Lazarus J.V., Ratziu V., Francque S.M., Sanyal A.J., Kanwal F., Romero D., Abdelmalek M.F., Anstee Q.M., Arab J.P., et al. A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature. J. Hepatol. 2023;79:1542–1556. doi: 10.1016/j.jhep.2023.06.003. - DOI - PubMed

Grants and funding

LinkOut - more resources